Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11623957 Heterodimeric antibodies that bind CD3 and PSMA

Patent 11623957 was granted and assigned to Xencor on April, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Xencor

Current Assignee

Xencor

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

116239570

Patent Inventor Names

Gregory Moore0

John Desjarlais0

Seung Chu0

Date of Patent

April 11, 2023

Patent Application Number

164895390

Date Filed

December 7, 2016

Patent Citations

‌

US Patent 10227410 Heterodimeric antibodies that bind CD3 and PSMA

‌

US Patent 10428155 Trispecific antibodies

‌

US Patent 10526417 Heterodimeric antibodies that bind CD3 and CD38

‌

US Patent 11066483 Cytotoxicity-inducing therapeutic agent

Patent Primary Examiner

CPC Code

The present invention is directed to heterodimeric antibodies that bind CD3 and PSMA.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11623957 Heterodimeric antibodies that bind CD3 and PSMA

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API